Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Pain Management Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Log In

Psoriasis (Ps) and Psoriatic Arthritis (PsA) Immunology and Treatment Targets

By: April Armstrong, MD, MPH

Webinar Credits: 1.0

Expiration Date: Saturday, September 04, 2021
Release Date: March 1, 2021

Learning Objectives

Identify updates on oral therapies for Psoriasis

Evaluate comparative efficacy of biologics for Psoriasis and Psoriatic Arthritis

Understand and Implement the AAD Psoriasis Guidelines

Accreditation and Designation Statement

  • Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, the Dermatology Education Foundation, and Physician Resources, LLC. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
  • Designation Statement
    Evolve Medical Education, LLC designates this enduring material for a maximum of  1 AMA PRA Category 1 Credits TM
    Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    PAs may claim a maximum of  1 Category 1 credits for completing this activity. National Commission on Certification of Physician Assistants (NCCPA) accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.
    The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM  from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
  • This activity is designated for 1 pharmacology hour.

Faculty and Disclosures

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

April Armstrong has had a financial agreement or affiliation during the past year with  the following commercial interests in the form of: Consultant: AbbVie, BI, Bristol-Myers Squibb, Dermira, Dermavant, Eli Lilly, EPI Health, Incyte, Janssen, LEO Pharma, Modernizing Medicine, Novartis AG, Ortho Dermatologics, Pfizer, Regeneron Pharmaceuticals, Sun Pharma, and UCB. Non-Promotional Speaker: AbbVie, Janssen. Grant/Research Support: Bristol-Myers Squibb, Dermavant, Dermira, Eli Lilly, and UCB.

Accreditation and Medical Education Support Disclosure

 Erin Fletcher of Evolve Medical Education LLC have no real or apparent conflicts of interest to report. 

Stacey Moore of Physician Resources, LLC has no real or apparent conflicts of interest to report.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education, Dermatology Education Foundation, Physician Resources or Leo Pharma.



  • Identify the co-factors in Atopic Dermatitis.
  • Critically appraise relevant evidence on pathophysiology and immunology as applied to Ps, PsA, and AD.
  • Identify the pathogenesis of AD.
  • Review the current and future treatment options of AD.

Step 1 of 2

  • AgreeNeutralDisagree
    Identify updates on oral therapies for Psoriasis
    Evaluate comparative efficacy of biologics for Psoriasis and Psoriatic Arthritis
    Understand and Implement the AAD Psoriasis Guidelines